CCL3 can stimulate cancer cell growth and migration (da Silva et al., 2017; Hsu et al., 2013), whereas blocking CCL3 can suppress tumor growth, and angiogenesis, and increase cell sensitivity to therapeutic drugs (Liao et al., 2016; Kim et al., 2017). Here, CCL3 is linked to cancer.